How has been the historical performance of the Lincoln Pharma.?

Answer:The historical performance of Lincoln Pharma shows a consistent growth trajectory in net sales and profits over the years. Breakdown: Lincoln Pharma's net sales have steadily increased from Rs 366.15 crore in March 2019 to Rs 623.23 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar pattern, rising from Rs 366.15 crore in March 2019 to Rs 623.23 crore in March 2025. The company's total expenditure, excluding depreciation, also grew from Rs 298.91 crore in March 2019 to Rs 521.74 crore in March 2025. Operating profit (PBDIT) has shown fluctuations, peaking at Rs 134.33 crore in March 2024 before slightly declining to Rs 123.97 crore in March 2025. Profit before tax reached Rs 109.19 crore in March 2025, down from Rs 122.24 crore in the previous year, while profit after tax was Rs 82.35 crore in March 2025, a decrease from Rs 93.30 crore in March 2024. The company's total assets increased from Rs 365.98 crore in March 2019 to Rs 700.29 crore in March 2024, indicating robust growth in its asset base. Cash flow from operating activities improved to Rs 63 crore in March 2024 from Rs 39 crore in March 2023, although the net cash inflow remained stable at Rs 0.00 in March 2024. Overall, Lincoln Pharma demonstrates a solid growth trajectory in sales and profits, despite some fluctuations in operating metrics.